Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4101
The Joint Corp
JYNT
$103M
| $281K | ﹤0.01% |
32,235
+1,623
| +5% | +$13.8K |
2019 Q1
27 quarters
|
|
4102
Sonida Senior Living
SNDA
$1.81B
| $280K | ﹤0.01% |
8,575
+704
| +9% | +$20.9K |
2024 Q1
7 quarters
|
|
4103
CALL
Deere & Co
DE
$185B
| $279K | ﹤0.01% |
600
| – | – |
2023 Q4
8 quarters
|
|
4104
Paysign
PAYS
$803M
| $279K | ﹤0.01% |
54,131
+1,504
| +3% | +$8.11K |
2023 Q2
10 quarters
|
|
4105
Invesco NASDAQ 100 ETF
QQQM
$110B
| $279K | ﹤0.01% |
1,102
-137,500
| -99% | -$34.7M |
2022 Q4
12 quarters
|
|
|
COSO
4106
CoastalSouth Bancshares
COSO
$323M
| $278K | ﹤0.01% |
11,971
+5,392
| +82% | +$120K |
2025 Q3
1 quarter
|
|
4107
Cardiff Oncology
CRDF
$87.1M
| $278K | ﹤0.01% |
98,863
+11,624
| +13% | +$27K |
2024 Q2
6 quarters
|
|
4108
EverCommerce
EVCM
$1.58B
| $277K | ﹤0.01% |
22,854
+1,101
| +5% | +$11.7K |
2022 Q1
15 quarters
|
|
|
IMSR
4109
Terrestrial Energy
IMSR
$400M
| $277K | ﹤0.01% |
+45,275
| New | +$605K |
2025 Q4
0 quarters
|
|
4110
RGC Resources
RGCO
$227M
| $277K | ﹤0.01% |
12,985
+1,288
| +11% | +$28.1K |
2022 Q3
13 quarters
|
|
|
VENU
4111
Venu Holding Corp
VENU
$79.1M
| $274K | ﹤0.01% |
+32,569
| New | +$361K |
2025 Q4
0 quarters
|
|
|
BRAG
4112
Bragg Gaming Group
BRAG
$37.3M
| $273K | ﹤0.01% |
130,200
| – | – |
2022 Q3
13 quarters
|
|
|
FIG
4113
PUT
Figma
FIG
$11.4B
| $273K | ﹤0.01% |
7,300
| – | – |
2025 Q3
1 quarter
|
|
4114
Douglas Elliman
DOUG
$141M
| $273K | ﹤0.01% |
114,996
+11,833
| +11% | +$30.4K |
2022 Q1
15 quarters
|
|
4115
FuelCell Energy
FCEL
$1.48B
| $271K | ﹤0.01% |
37,099
+37,097
| +1,854,850% | +$303K |
2019 Q4
24 quarters
|
|
4116
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.9B
| $270K | ﹤0.01% |
3,275
+890
| +37% | +$73.1K |
2023 Q2
10 quarters
|
|
|
AARD
4117
Aardvark Therapeutics
AARD
$109M
| $269K | ﹤0.01% |
20,516
-19,410
| -49% | -$242K |
2025 Q2
2 quarters
|
|
4118
PIMCO Corporate & Income Opportunity Fund
PTY
$2.45B
| $269K | ﹤0.01% |
+20,850
| New | +$282K |
2025 Q4
0 quarters
|
|
4119
Friedman Industries
FRD
$296M
| $268K | ﹤0.01% |
13,071
+1,119
| +9% | +$23K |
2024 Q3
5 quarters
|
|
|
CBK
4120
Commercial Bancgroup
CBK
$437M
| $267K | ﹤0.01% |
+10,886
| New | +$267K |
2025 Q4
0 quarters
|
|
4121
CALL
DexCom
DXCM
$32.2B
| $265K | ﹤0.01% |
4,000
| – | – |
2025 Q2
2 quarters
|
|
4122
Accuray
ARAY
$33.6M
| $265K | ﹤0.01% |
321,258
+9,644
| +3% | +$12K |
2013 Q2
50 quarters
|
|
4123
Baytex Energy
BTE
$3.24B
| $264K | ﹤0.01% |
81,854
+10,435
| +15% | +$29.1K |
2023 Q1
11 quarters
|
|
|
BZAI
4124
Blaize Holdings
BZAI
$69.5M
| $263K | ﹤0.01% |
135,013
+21,475
| +19% | +$69.5K |
2025 Q3
1 quarter
|
|
4125
iShares Russell 1000 Growth ETF
IWF
$130B
| $263K | ﹤0.01% |
2,224
-193,916
| -99% | -$23M |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.